SUBSCRIBE
SUBSCRIBE

Affinia Therapeutics

NEWS
Pictured: Abstract viruses and DNA
Drug Development
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases
Adeno-associated viruses have long been go-to vectors for gene therapies. How AAVs are improving will be among the cell and gene therapy topics to be covered in Baltimore this week.
May 3, 2024
 · 
4 min read
 · 
Mollie Barnes
Business
Money on the Move: April 29 – May 4
April showers bring May dollars. Here’s whose cash gardens are really blooming this week in the life sciences world.
May 5, 2021
 · 
5 min read
 · 
Kate Goodwin
JOBS
IN THE PRESS
Press Releases
Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics’ Pipeline of Next-Generation Gene Therapies to the Clinic
November 13, 2024
 · 
3 min read
Press Releases
Affinia Therapeutics to Highlight New Data on Genetic Cardiomyopathy Programs and BBB-Penetrant Capsids Leveraging Novel Receptors at the European Society of Gene & Cell Therapy 2024 31st Annual Congress
October 23, 2024
 · 
7 min read
Press Releases
Affinia Therapeutics to Participate in Upcoming Investor and Industry Conferences
September 23, 2024
 · 
1 min read
Press Releases
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
September 10, 2024
 · 
3 min read
Genetown
Affinia Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
May 28, 2024
 · 
1 min read
Drug Development
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell Therapy 2024 Annual Meeting
May 10, 2024
 · 
6 min read
Drug Development
Affinia Therapeutics to Present Data on Novel Cardiotropic and BBB-Penetrant AAV Capsids and Preclinical Efficacy and Safety in Genetic Cardiomyopathies and Sporadic ALS at the American Society of Gene & Cell Therapy 2024 Annual Meeting
April 22, 2024
 · 
5 min read
Drug Development
Affinia Therapeutics to Present Preclinical Data on Novel AAV Capsids at the 30th European Society of Gene and Cell Therapy 2023 Annual Congress
October 24, 2023
 · 
1 min read
Drug Development
Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting
May 18, 2023
 · 
3 min read
Drug Development
Affinia Therapeutics to Present New Data at the American Society of Gene and Cell Therapy Annual Meeting
May 3, 2023
 · 
1 min read
Load More